Whole genome analysis of human papillomavirus genotype 11 from cervix, larynx and lung

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 6, 2012, Pages 2619-2623

  Chansaenroj, Jira ^a   Theamboonlers, Apiradee ^a   Junyangdikul, Pairoj ^a   Supiyaphan, Pakpoom ^b   Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Samitivej Srinakharin Hospital   (Thailand)

Author keywords

Human Papillomavirus; Whole Genome

Indexed keywords

EID: 84874023710     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.6.2619     Document Type: Article

References (39)

1. Band V, Dalal S, Delmolino L, Androphy EJ (1993). Enhanced degradation of p53 protein in HPV- 6 and BPV-1 E6- immortalized human mammary epithelial cells, EMBO J, 12, 1847-52.
2. Barr E, Tamms G (2007). Quadrivalent human papillomavirus vaccine. Clin Infect Dis, 45, 609-17.
3. Broccolo F, Drago F, Careddu AM, et al. (2005). Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7. J Invest Dermatol, 124, 1234-40.
4. Burd EM (2003). Human papillomavirus and cervical cancer. Clin Microbiol Rev, 16, 1-17.
5. Chan SY, Delius H, Halpern AL, Bernard HU (1995). Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol, 69, 3074-83.
6. Chansaenroj J, Lurchachaiwong W, Termrungruanglert W, et al. (2010). Prevalence and genotypes of human papillomavirus among Thai women. Asian Pac J Cancer Prev, 11, 117-22.
7. Chin MT, Broker TR, Chow LT (1989). Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation. J Virol, 63, 2967-76.
8. Chinchai T, Chansaenroj J, Junyangdikul P, (2011). Comparison between direct sequencing and INNO-LiPA methods for HPV detection and genotyping in Thai Women. Asian Pac J Cancer Prev, 12, 989-94.
9. Derkay CS (2001). Recurrent respiratory papillomatosis. Laryngoscope, 111, 57-69.
10. Dickens P, Srivastava G, Loke SL, Larkin S (1991). Human papillomavirus 6, 11, and 16 in laryngeal papillomas. J Pathol, 165, 243-6.
11. Dilorenzo TP, Tamsen A, Abramson AL, Steinberg BM (1992). Human papillomavirus type 6a DNA in the lung carcinoma of a patient with recurrent laryngeal papillomatosis is characterized by a partial duplication. J Gen Virol, 73, 423-8.
12. Donne AJ, Hampson L, Homer JJ, Hampson IN (2010). The role of HPV type in Recurrent Respiratory Papillomatosis. Int J Pediatr Otorhinolaryngol, 74, 7-14.
13. D'Souza G, Dempsey A (2011). The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med, 1, 5-11.
14. Gáll T, Kis A, Fehér E, et al. (2011). Virological failure of intralesional cidofovir therapy in recurrent respiratory papillomatosis is not associated with genetic or epigenetic changes of HPV11: complete genome comparison of sequential isolates. Antiviral Res, 92, 356-8.
15. Gallagher TQ, Derkay CS (2009). Pharmacotherapy of recurrent respiratory papillomatosis: an expert opinion. Expert Opin Pharmacother, 10, 645-55.
16. Gissmann L, Wolnik L, Ikenberg H, et al. (1983). Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA, 80, 560-3.
17. Goon P, Sonnex C, Jani P, et al. (2008). Recurrent respiratory papillomatosis: an overview of current thinking and treatment. Eur Arch Otorhinolaryngol, 265, 147-51.
18. Hall TA (1999). BioEdit: a user-friendly biological sequence alignment editor and analysis program for windows 95/98/ NT. Nucleic acids symp. Ser, 41, 95-8.
19. Hebner CM, Laimins LA (2006). Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol, 16, 83-97.
20. Heinzel PA, Chan SY, Ho L, et al. (1995). Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol, 33, 1746- 54.
21. Hobbs CGL, Sterne JAC, Bailey M, et al. (2006). Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol, 31, 259-66.
22. Hubert WG (2005). Variant upstream regulatory region sequences differentially regulate human papillomavirus type 16 DNA replication throughout the viral life cycle. JVirol, 79, 5914-22.
23. Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005). Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev, 14, 467-75.
24. Lacey CJ, Lowndes CM, Shah KV (2006). Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine, 24, 35-41.
25. Lindman JP, Lewis LS, Accortt N, Wiatrak BJ (2005). Use of the Pediatric Quality of Life Inventory to assess the health-related quality of life in children with recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol, 114, 499-503.
26. Major T, Szarka K, Sziklai I, et al. (2005). The characteristics of human papillomavirus DNA in head and neck cancers and papillomas. J Clin Pathol, 58, 51-5.
27. Maloney EM, Unger ER, Tucker RA, et al. (2006). Longitudinal measures of human papillomavirus 6 and 11 viral loads and antibody response in children with recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg, 132, 711-5.
28. Reeves WC, Ruparelia SS, Swanson KI, et al. (2003). National registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg, 129, 976-82.
29. Rimell FL, Shoemaker DL, Pou AM, et al. (1997). Pediatric respiratory papillomatosis: prognostic role of viral typing and cofactors. Laryngoscope, 107, 915-8.
30. Rubben A, Beaudenon S, Favre M, et al. (1992). Rearrangements of the upstream regulatory region of human papillomavirus type 6 can be found in both Buschke-Lowenstein tumours and in condylomata acuminate. J Gen Virol, 73, 3147-53.
31. Schneider-Maunoury S, Croissant O, Orth G (1987). Integration of human papillomavirus type 16 DNA sequences: a possible early event in the progression of genital tumors, J Virol, 61, 3295-8.
32. Silverberg MJ, Thorsen P, Lindeberg H, et al. (2003). Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol, 101, 645-52.
33. Stamataki S, Nikolopoulos TP, Korres S, et al. (2007). Juvenile recurrent respiratory papillomatosis: still a mystery disease with difficult management. Head Neck, 29, 155-62.
34. Syrjanen K, Syrjanen S, Lamberg M, et al. (1983). Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg, 12, 418-24.
35. Tamura K, Dudley J, Nei M, Kumar S (2007). MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol, 24, 1596-99.
36. Tiersma ES, Van der Lee ML, Garssen B, et al. (2005). Psychosocial factors and the course of cervical intraepithelial neoplasia: a prospective study. Gynecol Oncol, 97, 879-86.
37. Uversky VN, Roman A, Oldfield CJ, Dunker AK (2006). Protein Intrinsic Disorder and Human Papillomaviruses: Increased Amount of Disorder in E6 and E7 Oncoproteins from High Risk HPVs. J Proteome Res, 5, 1829-42.
38. Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L (2004). Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope, 114, 1-23.
39. Zehbe I, Wilander E (1996). Two consensus primer systems and nested polymerase chain reaction for human papillomavirus detection in cervical biopsies: A study of sensitivity. Hum Pathol, 27, 812-5.